National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 23526-23527 [2020-08922]
Download as PDF
<![CDATA[
23526
Federal Register / Vol. 85, No. 82 / Tuesday, April 28, 2020 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—EHE NETWORK PLANNING PROGRAM
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
EHE Network Planning Grantee key personnel (Project Director) ...............................................................................
10
1
10
1
10
Total ..............................................................................
10
........................
10
........................
10
Dated: April 22, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–08967 Filed 4–27–20; 8:45 am]
BILLING CODE 4165–15–P
[FR Doc. 2020–08923 Filed 4–27–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The cooperative agreement
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the cooperative agreement applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
jbell on DSKJLSW7X2PROD with NOTICES
Total
responses
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HIV/AIDS Clinical Trials
Units (UM1 Clinical Trial Required).
Date: May 21–22, 2020.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G11,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Kumud K. Singh, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G11, Rockville, MD
20892, 301–761–7830, kumud.singh@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
18:43 Apr 27, 2020
Jkt 250001
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Dental
and Craniofacial Research Council.
The meeting will be open to the
public via NIH videocast. The URL link
to this meeting is: https://
videocast.nih.gov/watch=36304.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Dental and Craniofacial Research Council.
Date: May 19, 2020.
Open: 10:00 a.m. to 11:05 a.m.
Agenda: Report to the Director, NIDCR.
Place: National Institute Dental and
Craniofacial Research, National Institutes of
Health, 6701 Democracy Boulevard, Room
662, Bethesda, MD 20892. (Virtual Meeting)
Closed: 11:20 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute Dental and
Craniofacial Research, National Institutes of
Health, 6701 Democracy Boulevard, Room
662, Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Alicia J. Dombroski, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Dental and Craniofacial
Research, National Institutes of Health,
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Bethesda, MD 20892, 301–594–4805,
adombroski@nidcr.nih.gov.
Any interested person may submit written
comments no later than 15 days after the
meeting by forwarding the statement to
NIDCRCouncilMail@nidcr.nih.gov. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcr.nih.gov/about, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: April 21, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–08924 Filed 4–27–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The cooperative agreement
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the cooperative agreement applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases, Special
Emphasis Panel; HIV/AIDS Clinical Trials
Units (UM1 Clinical Trial Required).
Date: May 18–19, 2020.
E:\FR\FM\28APN1.SGM
28APN1
23527
Federal Register / Vol. 85, No. 82 / Tuesday, April 28, 2020 / Notices
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G11,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Kumud K. Singh, Ph.D.
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G11, MSC–9823,
Rockville, MD 20892, 301–761–7830,
kumud.singh@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 22, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–08922 Filed 4–27–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group Pathophysiological Basis of Mental
Disorders and Addictions Study Section.
Date: May 27–28, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Boris P. Sokolov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217A,
MSC 7846, Bethesda, MD 20892, 301–408–
9115, bsokolov@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
VerDate Sep<11>2014
18:43 Apr 27, 2020
Jkt 250001
Group Biobehavioral Regulation, Learning
and Ethology Study Section.
Date: May 28, 2020.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Unja Hayes, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda 20892, 301–827–
6830, unja.hayes@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel RFA–RM–
20–002: Tissue Mapping Centers for the
Human BioMolecular Atlas Program (U54).
Date: June 1–2, 2020.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kee Forbes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5148,
MSC 7806, Bethesda, MD 20892, 301–272–
4865, kee.forbes@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 22, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–08921 Filed 4–27–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Approval of Intertek USA, Inc. as a
Commercial Gauger; Wilmington, NC
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of approval of Intertek
USA, Inc. (Wilmington, NC), as a
commercial gauger.
AGENCY:
Notice is hereby given,
pursuant to CBP regulations, that
Intertek USA, Inc. (Wilmington, NC),
has been approved to gauge petroleum
and certain petroleum products for
customs purposes for the next three
years as of August 21, 2019.
DATES: Intertek USA, Inc. (Wilmington,
NC) was approved as a commercial
gauger as of August 21, 2019. The next
triennial inspection date will be
scheduled for August 2022.
SUMMARY:
PO 00000
Frm 00027
Fmt 4703
Sfmt 9990
FOR FURTHER INFORMATION CONTACT:
Allison Blair, Laboratories and
Scientific Services Directorate, U.S.
Customs and Border Protection, 4150
Interwood South Parkway, Houston, TX
77032, tel. 281–560–2924.
Notice is
hereby given pursuant to 19 CFR 151.13,
that Intertek USA, Inc., 116 Bryan Road,
Wilmington, NC 28412, has been
approved to gauge petroleum and
certain petroleum products for customs
purposes, in accordance with the
provisions of 19 CFR 151.13.
Intertek USA, Inc. (Wilmington, NC)
is approved for the following gauging
procedures for petroleum and certain
petroleum products from the American
Petroleum Institute (API):
SUPPLEMENTARY INFORMATION:
API chapters
Title
3 .....................
7 .....................
8 .....................
11 ...................
12 ...................
17 ...................
Tank Gauging.
Temperature Determination.
Sampling.
Physical Properties Data.
Calculations.
Marine Measurement.
Anyone wishing to employ this entity
to conduct gauger services should
request and receive written assurances
from the entity that it is approved by the
U.S. Customs and Border Protection to
conduct the specific gauger service
requested. Alternatively, inquiries
regarding the specific gauger service this
entity is accredited or approved to
perform may be directed to the U.S.
Customs and Border Protection by
calling (202) 344–1060. The inquiry may
also be sent to CBPGaugersLabs@
cbp.dhs.gov. Please reference the
website listed below for a complete
listing of CBP approved gaugers and
accredited laboratories. https://
www.cbp.gov/about/labs-scientific/
commercial-gaugers-and-laboratories.
Dated: April 9, 2020.
James D. Sweet,
Laboratory Director, Southwest Regional
Science Center, Laboratories and Scientific
Services Directorate.
[FR Doc. 2020–08959 Filed 4–27–20; 8:45 am]
BILLING CODE 9111–14–P
E:\FR\FM\28APN1.SGM
28APN1
]]>Agencies
[Federal Register Volume 85, Number 82 (Tuesday, April 28, 2020)]
[Notices]
[Pages 23526-23527]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08922]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The cooperative agreement applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the cooperative agreement
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases, Special Emphasis Panel; HIV/AIDS Clinical Trials Units
(UM1 Clinical Trial Required).
Date: May 18-19, 2020.
[[Page 23527]]
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G11,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Kumud K. Singh, Ph.D. Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room 3G11, MSC-9823,
Rockville, MD 20892, 301-761-7830, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: April 22, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-08922 Filed 4-27-20; 8:45 am]
BILLING CODE 4140-01-P
